MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

Search

Integra LifeSciences Holdings Corp

Fermé

SecteurSoins de santé

9.92 1.12

Résumé

Variation du prix de l'action

24h

Actuel

Min

9.86

Max

10.13

Chiffres clés

By Trading Economics

Revenu

3.7M

-1.7M

Ventes

33M

435M

Marge bénéficiaire

-0.392

Employés

4,427

EBITDA

12M

66M

Recommandations

By TipRanks

Recommandations

Vente

Prévisions sur 12 Mois

+14.45% upside

Dividendes

By Dow Jones

Prochains Résultats

4 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-191M

726M

Ouverture précédente

8.8

Clôture précédente

9.92

Sentiment de l'Actualité

By Acuity

50%

50%

185 / 348 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 avr. 2026, 17:04 UTC

Principaux Mouvements du Marché

FDA Rejects Replimune's Melanoma Drug for a Second Time

11 avr. 2026, 00:00 UTC

Résultats
Acquisitions, Fusions, Rachats

Big Yachts, Big Bucks -- Barrons.com

10 avr. 2026, 21:55 UTC

Acquisitions, Fusions, Rachats

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10 avr. 2026, 21:01 UTC

Résultats

Cango Inc.: Files Annual Report on Form 20-F With SEC

10 avr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

10 avr. 2026, 20:50 UTC

Market Talk
Principaux Événements d'Actualité

Basic Materials Roundup: Market Talk

10 avr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 avr. 2026, 20:31 UTC

Market Talk

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10 avr. 2026, 20:10 UTC

Acquisitions, Fusions, Rachats

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10 avr. 2026, 19:15 UTC

Market Talk

Global Energy Roundup: Market Talk

10 avr. 2026, 19:15 UTC

Market Talk

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10 avr. 2026, 19:08 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10 avr. 2026, 19:08 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

10 avr. 2026, 18:38 UTC

Market Talk

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

10 avr. 2026, 18:25 UTC

Market Talk
Principaux Événements d'Actualité

Precious Metals Finish With Weekly Gains -- Market Talk

10 avr. 2026, 18:05 UTC

Market Talk

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

10 avr. 2026, 17:31 UTC

Market Talk
Principaux Événements d'Actualité

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

10 avr. 2026, 17:26 UTC

Résultats

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

10 avr. 2026, 17:10 UTC

Market Talk

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

10 avr. 2026, 17:00 UTC

Principaux Événements d'Actualité

Construction Business Taking a Hit From Iran Conflict -- WSJ

10 avr. 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

10 avr. 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

10 avr. 2026, 16:12 UTC

Résultats

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

10 avr. 2026, 16:11 UTC

Résultats

Partners Group: Traditional Programs Contributed $3.3B

10 avr. 2026, 16:10 UTC

Résultats

Partners Group: $5B of New Commitments Came From Bespoke Solutions

10 avr. 2026, 16:10 UTC

Résultats

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

10 avr. 2026, 16:10 UTC

Résultats

Partners Group 1Q New Client Demand $8.3B

10 avr. 2026, 16:09 UTC

Résultats

Partners Group Continued to See Positive Fundraising Momentum in 1Q

10 avr. 2026, 15:54 UTC

Acquisitions, Fusions, Rachats

Plenitude Completes Acquisition of Acea Energia

10 avr. 2026, 15:38 UTC

Market Talk

Global Energy Roundup: Market Talk

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

14.45% hausse

Prévisions sur 12 Mois

Moyen 11.25 USD  14.45%

Haut 13 USD

Bas 9 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Vente

5 ratings

0

Achat

3

Maintien

2

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

185 / 348Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat